CompanyGraph
At a glance
- Depends onDownstream position: depends on 11 industries, supplies 6
- ScaleMarket cap is $1.92B, above the global median of $1.18B
- FinancialsAltman Z-Score 6.75: safe zone
- Interpretations1 currently firing — 1
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
2.67%Above 5Y avg (2.36%)
Annual Rate
IDR 20.00Paid annual
Payout Ratio
25.1%Sustainable
Payback Period
36.2 yr
Last Ex-Dividend
Jun 4, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
34.16TIDR1.92B · vs all stocks (USD)
Trailing P/E
9.43xRevenue (TTM)
37.72TIDR2.12B · vs all stocks (USD)
Profit Margin
9.57%Beta
-0.0710xvs all stocks
52-Week Change
-35.19%vs all stocks
Market Capitalization
34.16TIDR1.92B · vs all stocks (USD)
Enterprise Value
31.21TIDR1.75B · vs all stocks (USD)
Trailing P/E
9.43xForward P/E
10.03xPrice to Sales (TTM)
0.8996xPrice to Book (MRQ)
1.39xEnterprise to Revenue
0.8270xEnterprise to EBITDA
6.19xGross Margin
36.84%Profit Margin
9.57%Operating Margin
11.87%Return on Assets (TTM)
9.22%Return on Equity (TTM)
14.77%Revenue (TTM)
37.72TIDR2.12B · vs all stocks (USD)
Revenue per Share (TTM)
831.49IDRUpdated Sep 23, 2026Quarterly Revenue Growth
18.20%Gross Profit (TTM)
14.10TIDR790.99M · vs all stocks (USD)
EBITDA (TTM)
5.11TIDR286.61M · vs all stocks (USD)
Net Income (TTM)
3.61TIDR202.53M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
-0.80%Operating Cash Flow (TTM)
3.22TIDR180.90M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
1.98TIDR111.31M · vs all stocks (USD)
Trailing Annual Dividend Rate
20.00IDRUpdated Sep 23, 2026Trailing Annual Dividend Yield
2.67%vs all stocks
5-Year Average Dividend Yield
2.36%vs all stocks
Payout Ratio
25.13%Minority Interest (Equity)
1.42TIDRFY2025 · Dec 31, 2025Revenue
35.32TIDRFY2025 · Dec 31, 2025Cost of Goods Sold
21.27TIDRFY2025 · Dec 31, 2025Gross Profit
14.06TIDRFY2025 · Dec 31, 2025Operating Income
4.55TIDR255.02M · vs all stocks (USD)
Pre-tax Income
4.78TIDRFY2025 · Dec 31, 2025Income Tax Expense
1.03TIDRFY2025 · Dec 31, 2025Net Income
3.74TIDRFY2025 · Dec 31, 2025EBIT
4.81TIDRFY2025 · Dec 31, 2025EBITDA (Income Statement)
5.11TIDRFY2025 · Dec 31, 2025Research & Development
499.71BIDRFY2025 · Dec 31, 2025Selling, General & Administrative
5.45TIDRFY2025 · Dec 31, 2025Other Operating Expenses
642.86BIDRFY2025 · Dec 31, 2025Non-operating Interest Income
179.20BIDRFY2025 · Dec 31, 2025Non-operating Interest Expense
35.25BIDRFY2025 · Dec 31, 2025EPS (Basic)
80.51IDRFY2025 · Dec 31, 2025EPS (Diluted)
80.51IDRFY2025 · Dec 31, 2025Basic Shares Outstanding
45.52BSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
45.52BSharesFY2025 · Dec 31, 2025Minority Interests (P&L)
-79.38BIDRFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00IDRFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
4.33TIDRFY2025 · Dec 31, 2025Capital Expenditures
-528.27BIDRFY2025 · Dec 31, 2025Net Intangibles (CF)
-73.55BIDRFY2025 · Dec 31, 2025Net Acquisitions
-384.98BIDRFY2025 · Dec 31, 2025Purchase of Investments
-36.02BIDRFY2025 · Dec 31, 2025Sale of Investments
0.00IDRFY2025 · Dec 31, 2025Net Investing Cash Flow
-949.27BIDRFY2025 · Dec 31, 2025Long-term Debt Issuance
0.00IDRFY2025 · Dec 31, 2025Long-term Debt Payments
-1.09TIDRFY2025 · Dec 31, 2025Net Short-term Debt Issuance
-156.75BIDRFY2025 · Dec 31, 2025Common Stock Repurchase
-842.09BIDRFY2025 · Dec 31, 2025Common Dividends Paid
-1.64TIDRFY2025 · Dec 31, 2025Other Financing Charges
-806.00MIDRFY2025 · Dec 31, 2025Net Financing Cash Flow
-3.73TIDRFY2025 · Dec 31, 2025Shares Outstanding
45.25BSharesUpdated Sep 23, 2026Float Shares
18.00BSharesUpdated Sep 23, 2026% Held by Insiders
64.87%vs all stocks
% Held by Institutions
11.13%vs all stocks
Total Cash (MRQ)
4.99TIDR279.72M · vs all stocks (USD)
Total Cash per Share (MRQ)
110.17IDRUpdated Sep 23, 2026Total Debt (MRQ)
826.48BIDR46.37M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.0321xCurrent Ratio (MRQ)
3.15xBook Value per Share (MRQ)
537.67IDRUpdated Sep 23, 2026Total Assets
30.70TIDR1.72B · vs all stocks (USD)
Total Current Assets
18.51TIDRFY2025 · Dec 31, 2025Total Liabilities
5.97TIDRFY2025 · Dec 31, 2025Total Non-current Assets
12.19TIDRFY2025 · Dec 31, 2025Total Non-current Liabilities
634.69BIDRFY2025 · Dec 31, 2025Total Current Liabilities
5.34TIDRFY2025 · Dec 31, 2025Cash
2.53TIDRFY2025 · Dec 31, 2025Cash Equivalents
1.80TIDRFY2025 · Dec 31, 2025Cash & Cash Equivalents
4.33TIDRFY2025 · Dec 31, 2025Other Short-term Investments
154.14BIDRFY2025 · Dec 31, 2025Accounts Receivable
5.65TIDRFY2025 · Dec 31, 2025Inventory
6.99TIDRFY2025 · Dec 31, 2025Accounts Payable
2.40TIDRFY2025 · Dec 31, 2025Short-term Debt
133.56BIDRFY2025 · Dec 31, 2025Long-term Debt
163.72BIDRFY2025 · Dec 31, 2025Common Stock (Book)
468.13BIDRFY2025 · Dec 31, 2025Retained Earnings
24.94TIDRFY2025 · Dec 31, 2025Total Shareholders' Equity
24.73TIDR1.39B · vs all stocks (USD)
Treasury Stock
2.21TIDRFY2025 · Dec 31, 202552-Week Low
630.00IDRUpdated Sep 23, 202652-Week High
1.34KIDRUpdated Sep 23, 202652-Week Change
-35.19%vs all stocks
Beta
-0.0710xvs all stocks
50-Day MA
762.70IDRUpdated Sep 23, 2026200-Day MA
930.42IDRUpdated Sep 23, 2026Avg 10-Day Volume
80.59MSharesUpdated Sep 23, 2026Avg 30-Day Volume
77.71MSharesUpdated Sep 23, 2026Diluted EPS (TTM)
79.57IDRUpdated Sep 23, 20261 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsIs this company growing?
Multi-Year Revenue, Profit, And Income Growth
Revenue has risen in each of three years, gross profit in each of four, and it has made a profit in all five.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 6.75: safe zoneNotable
Altman Z-Score: 6.75
Supply Chain
Downstream position: depends on 11 industries, supplies 6Notable
Outgoing: 6.00Incoming: 11.00
High connectivity hub: 17 industry connectionsNotable
Total Connections: 17.00
Scale
Market cap is $1.92B, above the global median of $1.18BNotable
Market cap (USD): 1,916,879,723.283Global Median: 1,180,223,658.953
Revenue is $2.12B, above the global median of $548.88MNotable
Revenue (USD): 2,116,696,822.293Global Median: 548,883,780.48
Levered free cash flow is $111.31M, above the global median of $18.73MNotable
Levered free cash flow (USD): 111,309,776.046Global Median: 18,729,043.027
Companies that share the same coordination system — how they create, deliver, or capture value.
Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
ChemoMetec A/S
Tier 1ProductionApproval-Gated PipelineRule
OneSource Specialty Pharma Inc.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Jinyu Bio-Technology Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Shanghai Innostar Bio-tech Co., Ltd.
Tier 1ProductionApproval-Gated PipelineSenseMakingRule
Xencor Inc.
Tier 1ProductionApproval-Gated PipelineRuleRisk
Zymeworks Inc.
Tier 1ProductionApproval-Gated PipelineRule
Agios Pharmaceuticals Inc.
Tier 1ProductionApproval-Gated PipelineRuleRisk
Inner Mongolia Furui Medical Science Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Nektar Therapeutics Inc.
Tier 1ProductionApproval-Gated PipelineRule
Companies that share active interpretations — structural patterns currently present in both stocks.
Tianjin Ringpu Bio-Technology Co., Ltd.
1 interpretationMulti-Year Revenue, Profit, And Income Growth
Shenzhen Inovance Technology Co., Ltd.
1 interpretationMulti-Year Revenue, Profit, And Income Growth
Five-Star Business Finance Limited
1 interpretationMulti-Year Revenue, Profit, And Income Growth